Central venous access devices for paediatric patients with haemophilia: A single-institution experience

Haemophilia

Volumn 15, Issue 1, 2009, Pages 168-174

  Titapiwatanakun, R ^a   Moir, C ^b   Pruthi, R K ^c   Stavlo, P L ^b   Schmidt, K A ^a   Rodriguez, Vilmarie ^a,c  

^a Division of Pediatric Hematology and Oncology   (United States)

^b Division of Pediatric Surgery   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Central venous catheterization; Complication; Factor VIII deficiency; Haemophilia A; Haemophilia B; Von Willebrand disease

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 9;

ARTICLE; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER REMOVAL; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CHILD; CHILD CARE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INFANT; INFECTION RATE; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES; VON WILLEBRAND DISEASE;

BACTERIAL INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; EQUIPMENT CONTAMINATION; FACTOR IX; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HOME INFUSION THERAPY; HUMANS; INFANT; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRAVENOUS; MALE; RETROSPECTIVE STUDIES; VON WILLEBRAND DISEASE;

EID: 63049091322     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01906.x     Document Type: Article

References (25)

1. Van Den Berg HM, Fischer K, Roosendaal G, Mauser-Bunschoten EP. The use of the Port-A-Cath in children with haemophilia: A review. Haemophilia 1998; 4: 418-20.
2. Medical and Scientific Advisory Council (MASAC) document #179. MASAC recommendation concerning prophylaxis (regular administration of clotting factor concentrate to prevent bleeding). New York: National Hemophilia Foundation; November 2007.
3. Hothi DK, Kelsall W, Baglin T, Williams DM. Bacterial endocarditis in a child with haemophilia B: Risks of central venous catheters. Haemophilia 2001; 7: 507-10.
4. Li CH, Ou Y, Lee AC, So KT. Septic arthritis in hemophilia with central venous catheter: A case report. Pediatr Hematol Oncol 2000; 17: 187-9.
5. Borow M, Crowley JG. Evaluation of central venous catheter thrombogenicity. Acta Anaesthesiol Scand Suppl 1985; 81: 59-64.
6. Petersen J, Delaney JH, Brakstad MT, Rowbotham RK, Bagley CM Jr. Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction. Am J Surg 1999; 178: 38-41.
7. National Healthcare Safety Network (NHSN) surveillance definitions: central line associated bloodstream infection (CLABSI) and related sites. Atlanta (GA): CDC; developed by MHA-KICU Infectious Disease Advisory Group. Provided by NHSN, Division of Healthcare Quality Promotion, CDC, 2006.
8. Levine PH. Efficacy of self-therapy in hemophilia: A study of 72 patients with hemophilia A and B. N Engl J Med 1974; 291: 1381-4.
9. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
10. Hacker MR, Page JH, Shapiro AD, Rich-Edwards JW, Manco-Johnson MJ. Central venous access device infections in children with hemophilia: A comparison of prophylaxis and episodic therapy. J Pediatr Hematol Oncol 2007; 29: 458-64.
11. Ewenstein BM, Valentino LA, Journeycake JM et al. Consensus recommendations for use of central venous access devices in haemophilia. Haemophilia 2004; 10: 629-48.
12. Ljung R. Central venous catheters in children with haemophilia. Blood Rev 2004; 18: 93-100.
13. Morado M, Jimenez-Yuste V, Villar A et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001; 7: 551-6.
14. Miller K, Buchanan GR, Zappa S et al. Implantable venous access devices in children with hemophilia: A report of low infection rates. J Pediatr 1998; 132: 934-8.
15. Van Dijk K, Van Der Bom JG, Bax KN, Van Der Zee DC, Van Den Berg MH. Use of implantable venous access devices in children with severe hemophilia: benefits and burden. Haematologica 2004; 89: 189-94.
16. Liesner RJ, Vora AJ, Hann IM, Lilleymann JS. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995; 91: 203-7.
17. Bollard CM, Teague LR, Berry EW, Ockelford PA. The use of central venous catheters (portacaths) in children with haemophilia. Haemophilia 2000; 6: 66-70.
18. Santagostino E, Gringeri A, Muca-Perja M, Mannucci PM. A prospective clinical trial of implantable central venous access in children with haemophilia. Br J Haematol 1998; 102: 1224-8.
19. Collins PW, Khair KS, Liesner R, Hann IM. Complications experienced with central venous catheters in children with congenital bleeding disorders. Br J Haematol 1997; 99: 206-8.
20. Ljung R. Central venous lines in haemophilia. Haemophilia 2003; 9(Suppl 1): 88-92.
21. Valentino LA, Ewenstein B, Navickis RJ, Wilkes MM. Central venous access devices in haemophilia. Haemophilia 2004; 10: 134-46.
22. Ljung R, van den Berg M, Petrini P et al. Port-A-Cath usage in children with haemophilia: Experience of 53 cases. Acta Paediatr 1998; 87: 1051-4.
23. Tarantino MD, Lail A, Donfield SM et al. Surveillance of infectious complications associated with central venous access devices in children with haemophilia. Haemophilia 2003; 9: 588-92.
24. Perkins JL, Johnson VA, Osip JM et al. The use of implantable venous access devices (IVADs) in children with hemophilia. J Pediatr Hematol Oncol 1997; 19: 339-44.
25. Domm JA, Hudson MG, Janco RL. Complications of central venous access devices in paediatric haemophilia patients. Haemophilia 2003; 9: 50-6.